Published in J Bacteriol on February 01, 1980
Methanogens and the diversity of archaebacteria. Microbiol Rev (1987) 7.77
Specific antisera and immunological procedures for characterization of methanogenic bacteria. J Bacteriol (1982) 2.92
Influence of corrinoid antagonists on methanogen metabolism. J Bacteriol (1981) 2.58
Microbial formation of ethane in anoxic estuarine sediments. Appl Environ Microbiol (1981) 2.04
Carbon monoxide-dependent methyl coenzyme M methylreductase in acetotrophic Methosarcina spp. J Bacteriol (1984) 2.00
One-carbon metabolism in methanogens: evidence for synthesis of a two-carbon cellular intermediate and unification of catabolism and anabolism in Methanosarcina barkeri. J Bacteriol (1982) 1.89
Coenzyme M derivatives and their effects on methane formation from carbon dioxide and methanol by cell extracts of Methanosarcina barkeri. J Bacteriol (1981) 1.70
Levels of coenzyme F420, coenzyme M, hydrogenase, and methylcoenzyme M methylreductase in acetate-grown Methanosarcina. Appl Environ Microbiol (1981) 1.66
Identification of methyl coenzyme M as an intermediate in methanogenesis from acetate in Methanosarcina spp. J Bacteriol (1984) 1.47
Stable Carbon Isotope Fractionation by Methanosarcina barkeri during Methanogenesis from Acetate, Methanol, or Carbon Dioxide-Hydrogen. Appl Environ Microbiol (1987) 1.38
Reduced coenzyme F420: heterodisulfide oxidoreductase, a proton- translocating redox system in methanogenic bacteria. Proc Natl Acad Sci U S A (1990) 1.36
Reversal of 2-bromoethanesulfonate inhibition of methanogenesis in Methanosarcina sp. J Bacteriol (1983) 1.35
Activation and inactivation of methanol: 2-mercaptoethanesulfonic acid methyltransferase from Methanosarcina barkeri. J Bacteriol (1983) 1.29
Purification and properties of methanol:5-hydroxybenzimidazolylcobamide methyltransferase from Methanosarcina barkeri. J Bacteriol (1984) 1.29
Acetate-dependent methylation of two corrinoid proteins in extracts of Methanosarcina barkeri. J Bacteriol (1991) 1.19
Utilization of Methanol plus Hydrogen by Methanosarcina barkeri for Methanogenesis and Growth. Appl Environ Microbiol (1986) 1.17
Acetate catabolism by Methanosarcina barkeri: evidence for involvement of carbon monoxide dehydrogenase, methyl coenzyme M, and methylreductase. J Bacteriol (1985) 1.13
The methanoreductosome: a high-molecular-weight enzyme complex in the methanogenic bacterium strain Gö1 that contains components of the methylreductase system. J Bacteriol (1988) 1.02
Formation of trideuteromethane from deuterated trimethylamine or methylamine by Methanosarcina barkeri. J Bacteriol (1981) 0.91
Immunoelectron microscopic demonstration of ATPase on the cytoplasmic membrane of the methanogenic bacterium strain Göl. J Bacteriol (1987) 0.90
Involvement of an activation protein in the methanol:2-mercaptoethanesulfonic acid methyltransferase reaction in Methanosarcina barkeri. J Bacteriol (1993) 0.89
Immunocytochemical localization of the coenzyme F420-reducing hydrogenase in Methanosarcina barkeri Fusaro. J Bacteriol (1991) 0.81
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
FORMATION OF METHANE BY BACTERIAL EXTRACTS. J Biol Chem (1963) 24.25
New approach to the cultivation of methanogenic bacteria: 2-mercaptoethanesulfonic acid (HS-CoM)-dependent growth of Methanobacterium ruminantium in a pressureized atmosphere. Appl Environ Microbiol (1976) 15.95
A new coenzyme of methyl transfer, coenzyme M. Biochemistry (1971) 7.70
Structure and methylation of coenzyme M(HSCH2CH2SO3). J Biol Chem (1974) 7.53
Studies on the methane fermentation. XII. The pathway of hydrogen in the acetate fermentation. J Bacteriol (1956) 7.25
Phosphorylation coupled to the oxidation of ferrocytochrome c. J Biol Chem (1955) 6.72
The methane fermentations of acetate and methanol. J Bacteriol (1957) 6.40
Studies on the methane fermentation. IX. The origin of methane in the acetate and methanol fermentations by methanosarcina. J Bacteriol (1951) 6.21
Preparation of coenzyme M analogues and their activity in the methyl coenzyme M reductase system of Methanobacterium thermoautotrophicum. Biochemistry (1978) 5.90
Utilization of trimethylamine and other N-methyl compounds for growth and methane formation by Methanosarcina barkeri. Proc Natl Acad Sci U S A (1979) 4.04
Growth and methanogenesis by Methanosarcina strain 227 on acetate and methanol. Appl Environ Microbiol (1978) 3.70
One carbon metabolism in methanogenic bacteria. Cellular characterization and growth of Methanosarcina barkeri. Arch Microbiol (1978) 3.52
ATP requirement for methanogenesis in cell extracts of methanobacterium strain M.o.H. Biochim Biophys Acta (1969) 3.13
Specificity and biological distribution of coenzyme M (2-mercaptoethanesulfonic acid). J Bacteriol (1979) 2.95
Distribution of coenzyme F420 and properties of its hydrolytic fragments. J Bacteriol (1979) 2.18
Methane biosynthesis by Methanosarcina barkeri. Properties of the soluble enzyme system. Arch Biochem Biophys (1966) 2.06
ATP-DEPENDENT FORMATION OF METHANE FROMMETHYLCOBALAMIN BY EXTRACTS OF METHANOBACILLUS OMELIANSKII. Biochem Biophys Res Commun (1963) 1.99
Complete degradation of carbohydrate to carbon dioxide and methane by syntrophic cultures of Acetobacterium woodii and Methanosarcina barkeri. Arch Microbiol (1979) 1.79
Cobamide-dependent methanol-cyanocob(I)alamin methyltransferase of Methanosarcina barkeri. Arch Biochem Biophys (1968) 1.38
Biosynthesis of methane from the methyl moiety of methylcobalamin. Biochem Biophys Res Commun (1963) 1.21
Methanogens: reevaluation of a unique biological group. Microbiol Rev (1979) 29.84
The phylogeny of prokaryotes. Science (1980) 24.57
New approach to the cultivation of methanogenic bacteria: 2-mercaptoethanesulfonic acid (HS-CoM)-dependent growth of Methanobacterium ruminantium in a pressureized atmosphere. Appl Environ Microbiol (1976) 15.95
Ten- to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst (1982) 13.25
Fine structure of Methanobacterium thermoautotrophicum: effect of growth temperature on morphology and ultrastructure. J Bacteriol (1973) 13.12
Methanobacillus omelianskii, a symbiotic association of two species of bacteria. Arch Mikrobiol (1967) 11.83
Promotion of Breastfeeding Intervention Trial (PROBIT): a randomized trial in the Republic of Belarus. JAMA (2001) 11.31
Microbial formation of methane. Adv Microb Physiol (1971) 9.69
Methanobacterium thermoautotrophicus sp. n., an anaerobic, autotrophic, extreme thermophile. J Bacteriol (1972) 9.14
Evidence on screening for breast cancer from a randomized trial. Cancer (1977) 7.91
A new coenzyme of methyl transfer, coenzyme M. Biochemistry (1971) 7.70
Structure and methylation of coenzyme M(HSCH2CH2SO3). J Biol Chem (1974) 7.53
Isolation and properties of a fluorescent compound, factor 420 , from Methanobacterium strain M.o.H. J Bacteriol (1972) 6.94
Hydrogen-oxidizing methane bacteria. I. Cultivation and methanogenesis. J Bacteriol (1968) 6.21
Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst (1993) 6.02
Periodic breast cancer screening in reducing mortality from breast cancer. JAMA (1971) 5.91
Preparation of coenzyme M analogues and their activity in the methyl coenzyme M reductase system of Methanobacterium thermoautotrophicum. Biochemistry (1978) 5.90
Anaerobic degradation of benzoate to methane by a microbial consortium. Arch Microbiol (1976) 5.87
Viologen dye inhibition of methane formation by Methanobacillus omelianskii. J Bacteriol (1964) 5.35
Classification of methanogenic bacteria by 16S ribosomal RNA characterization. Proc Natl Acad Sci U S A (1977) 5.09
Adenosine triphosphate pools in Methanobacterium. J Bacteriol (1970) 4.41
Nutrition and carbon metabolism of Methanococcus voltae. J Bacteriol (1982) 4.27
Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product. Lancet (1996) 4.21
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial. Ann Intern Med (2000) 4.07
Coenzyme M, essential for growth of a rumen strain of Methanobacterium ruminantium. J Bacteriol (1974) 3.92
Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA (1993) 3.71
Isolation and pure culture of a freshwater magnetic spirillum in chemically defined medium. J Bacteriol (1979) 3.63
The reluctant participant in a breast cancer screening program. Public Health Rep (1968) 3.60
Proposed structure for coenzyme F420 from Methanobacterium. Biochemistry (1978) 3.59
Utilization of health and mental health services. Three Epidemiologic Catchment Area sites. Arch Gen Psychiatry (1984) 3.55
A comparison of the requirements for primary care physicians in HMOs with projections made by the GMENAC. N Engl J Med (1986) 3.54
Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet (1997) 3.40
Effect of questionnaire design on recall of drug exposure in pregnancy. Am J Epidemiol (1986) 3.34
Five-year blood pressure control and mortality following health education for hypertensive patients. Am J Public Health (1983) 3.33
Magnetite in freshwater magnetotactic bacteria. Science (1979) 3.25
Comparison of the lay Diagnostic Interview Schedule and a standardized psychiatric diagnosis. Experience in eastern Baltimore. Arch Gen Psychiatry (1985) 3.18
ATP requirement for methanogenesis in cell extracts of methanobacterium strain M.o.H. Biochim Biophys Acta (1969) 3.13
Characterization of a small proteolytic enzyme which lyses bacterial cell walls. J Bacteriol (1966) 3.09
Oral-contraceptive use in relation to myocardial infarction. Lancet (1979) 3.04
Unusual coenzymes of methanogenesis. Annu Rev Biochem (1990) 3.01
Efficacy and toxicity of heparin in relation to age and sex. N Engl J Med (1968) 2.99
A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst (1991) 2.96
Specificity and biological distribution of coenzyme M (2-mercaptoethanesulfonic acid). J Bacteriol (1979) 2.95
Comprehensive drug surveillance. JAMA (1970) 2.92
Nutritional and biochemical characterization of Methanospirillum hungatii. Appl Environ Microbiol (1977) 2.83
Hydrogen-oxidizing methane bacteria. II. Electron microscopy. J Bacteriol (1968) 2.81
Mammography and clinical examination in mass screening for cancer of the breast. Cancer (1967) 2.80
Functional recovery and medical costs of trauma: an analysis by type and severity of injury. J Trauma (1988) 2.74
Antenatal exposure to doxylamine succinate and dicyclomine hydrochloride (Benedectin) in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score. Am J Obstet Gynecol (1977) 2.65
Growth and plating efficiency of methanococci on agar media. Appl Environ Microbiol (1983) 2.65
The risk of myocardial infarction after quitting smoking in men under 55 years of age. N Engl J Med (1985) 2.64
Factor 420-dependent pyridine nucleotide-linked hydrogenase system of Methanobacterium ruminantium. J Bacteriol (1975) 2.58
Induction of an active transport system for glucose 6-phosphate in Escherichia coli. Arch Biochem Biophys (1966) 2.53
A genetic system for Archaea of the genus Methanosarcina: liposome-mediated transformation and construction of shuttle vectors. Proc Natl Acad Sci U S A (1997) 2.51
Mental health and social characteristics of the homeless: a survey of mission users. Am J Public Health (1986) 2.50
Stimulation of CO2 reduction to methane by methylcoenzyme M in extracts Methanobacterium. Biochem Biophys Res Commun (1977) 2.50
Drug rash with ampicillin and other penicillins. Lancet (1969) 2.50
SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo. Proc Natl Acad Sci U S A (2001) 2.49
A case-control study of baldness in relation to myocardial infarction in men. JAMA (1993) 2.49
Component C of the methylreductase system of Methanobacterium. J Biol Chem (1981) 2.47
An ancient divergence among the bacteria. J Mol Evol (1977) 2.44
Biosynthesis of dimethylarsine by Methanobacterium. Biochemistry (1971) 2.44
Venous thromboembolic disease and ABO blood type. A cooperative study. Lancet (1969) 2.38
Methyl coenzyme M reductase from Methanobacterium thermoautotrophicum. Resolution and properties of the components. J Biol Chem (1980) 2.37
Factor 420-dependent pyridine nucleotide-linked formate metabolism of Methanobacterium ruminantium. J Bacteriol (1975) 2.37
Impact of efforts to increase participation in repetitive screenings for early breast cancer detection. Am J Public Health (1972) 2.35
Breast cancer and cigarette smoking: a hypothesis. Am J Epidemiol (1991) 2.35
Race, family income, and low birth weight. Am J Epidemiol (1991) 2.30
Transport of coenzyme M (2-mercaptoethanesulfonic acid) in Methanobacterium ruminantium. J Bacteriol (1979) 2.28
Current practice of artificial insemination by donor in the United States. N Engl J Med (1979) 2.24
Medical economics survey-methods study: cost-effectiveness of alternative survey strategies. Med Care (1978) 2.22
Distribution of coenzyme F420 and properties of its hydrolytic fragments. J Bacteriol (1979) 2.18
Limited Pap screening associated with reduced risk of cervical cancer in South Africa. Int J Epidemiol (2003) 2.17
A multicenter, randomized, double-blinded trial of pyridostigmine in postpolio syndrome. Neurology (1999) 2.16
The search for risk factors in breast cancer. Am J Public Health Nations Health (1968) 2.16
The economic impact of traumatic injuries. One-year treatment-related expenditures. JAMA (1988) 2.15
Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]. Proc Natl Acad Sci U S A (1980) 2.13
Anaerobic growth of purple nonsulfur bacteria under dark conditions. J Bacteriol (1970) 2.12
The Abbreviated Injury Scale and Injury Severity Score. Levels of inter- and intrarater reliability. Med Care (1985) 2.11
Proceedings: A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh (1975) 2.10
Molecular, genetic, and biochemical characterization of the serC gene of Methanosarcina barkeri Fusaro. J Bacteriol (1996) 2.09
Prepregnant weight in relation to risk of neural tube defects. JAMA (1996) 2.02
Graduated compression stockings to treat acute leg pain associated with proximal DVT. A randomised controlled trial. Thromb Haemost (2014) 2.02
Evaluation of periodic breast cancer screening with mammography. Methodology and early observations. JAMA (1966) 2.00
Pseudobacteremia attributed to contamination of povidone-iodine with Pseudomonas cepacia. Ann Intern Med (1981) 1.96
Nickel-containing factor F430: chromophore of the methylreductase of Methanobacterium. Proc Natl Acad Sci U S A (1982) 1.96
Decline in the risk of myocardial infarction among women who stop smoking. N Engl J Med (1990) 1.95
ATP activation and properties of the methyl coenzyme M reductase system in Methanobacterium thermoautotrophicum. J Bacteriol (1978) 1.95
Reproductive factors and risk of myocardial infarction. Am J Epidemiol (1992) 1.94
Tetrahydromethanopterin, a carbon carrier in methanogenesis. J Biol Chem (1984) 1.94
Presence of nickel in factor F430 from Methanobacterium bryantii. Biochem Biophys Res Commun (1980) 1.93
The reaction of multihalogenated hydrocarbons with free and bound reduced vitamin B 12. Biochemistry (1968) 1.93
Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. Proc Natl Acad Sci U S A (1999) 1.91
Multivitamin supplementation and risk of birth defects. Am J Epidemiol (1999) 1.91
Structure of component B (7-mercaptoheptanoylthreonine phosphate) of the methylcoenzyme M methylreductase system of Methanobacterium thermoautotrophicum. Proc Natl Acad Sci U S A (1986) 1.89
Noncontraceptive estrogens and myocardial infarction in young women. JAMA (1980) 1.88
Selection, follow-up, and analysis in the Health Insurance Plan Study: a randomized trial with breast cancer screening. Natl Cancer Inst Monogr (1985) 1.87
End result measurements of quality of medical care. Milbank Mem Fund Q (1967) 1.87
Relevance of correlates of infant deaths for significant morbidity at 1 year of age. Am J Obstet Gynecol (1980) 1.85
Prognosis of men after first myocardial infarction: mortality and first recurrence in relation to selected parameters. Am J Public Health Nations Health (1968) 1.85